Zimmer Biomet Received FDA Approval for Oxford® Cementless Partial Knee, the Only Cementless Partial Knee Replacement Implant in the U.S.
On November 25, 2024, Zimmer Biomet Holdings, Inc., a global leader in medical technology, announced that its Oxford® Cementless Partial Knee received Premarket Approval Application (PMA) Supplement approval from the U.S. Food and Drug Administration (FDA). The approval was granted based on data from an Investigational Device Exemption (IDE) study and non-clinical testing, demonstrating safety and effectiveness for cementless partial knee replacement (PKR).
The Oxford Cementless Partial Knee was shown to enhance fixation...
